These findings help understand the role of IL-22 in cancer development, especially in tumor cell metastasis and invasion stages, and provide a theoretical basis for developing molecular therapeutic strategies targeting IL-22 and AKT signaling pathways. Here, AKT1 is linked to neoplasm.